- Tytuł:
-
Can neoadjuvant systemic therapy provide additional benefits for
T1 HER2+ breast cancer patients: a subgroup analysis based on different high-risk signatures - Autorzy:
- Źródło:
- Clinical and Translational Oncology. :1-16
Czasopismo naukowe